市場調査レポート

在宅注入療法市場分析:製品別 (注入ポンプ、静注セット、IVカニューレ、ニードレスコネクター)、用途別、および2022年までのセグメント予測

Home Infusion Therapy Market Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application And Segment Forecasts To 2022

発行 Grand View Research, Inc. 商品コード 342348
出版日 ページ情報 英文 87 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
在宅注入療法市場分析:製品別 (注入ポンプ、静注セット、IVカニューレ、ニードレスコネクター)、用途別、および2022年までのセグメント予測 Home Infusion Therapy Market Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application And Segment Forecasts To 2022
出版日: 2015年04月20日 ページ情報: 英文 87 Pages
概要

世界の在宅注入療法市場は2022年までに319億米ドルに達すると予測されています。慢性疾患の発生率上昇が外来における注入療法の需要を拡大しています。また世界的な高齢化も市場を拡大する大きな要因となっています。

当レポートでは、世界の在宅注入療法市場について分析し、製品別、用途別見通しとともに、地域別動向などをまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 在宅注入療法業界見通し

  • 市場セグメンテーション
  • 市場規模と成長見通し
  • 市場動向
    • 促進因子
    • 阻害因子
  • 優先される主な機会
  • 業界分析:ポーターズ
  • PESTEL分析
  • アンメットニーズ分析

第4章 製品見通し

  • 製品別市場シェア
  • 注入ポンプ
  • 静注セット
  • ニードレスコネクター

第5章 用途別見通し

  • 用途別市場シェア
  • 抗炎症
  • 水和療法
  • 化学療法
  • 経腸栄養
  • 非経口栄養
  • 特殊医薬品
  • その他

第6章 地域別見通し

  • 地域別市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合環境

  • テルモ株式会社
  • B. Braun Melsungen
  • Caesarea Medical Electronics
  • Smiths Medical
  • CareFusion Corporation
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • Baxter Inc
  • Fresenius Kabi

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 978-1-68038-389-8

Global Home Infusion Therapy Market is expected to reach USD 31.9 billion by 2022, according to a new study by Grand View Research Inc. Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings.

Further key findings from the study suggest:

Needleless connectors are expected to witness lucrative growth over the forecast period. Growing demand for enhanced healthcare service provider safety has led to the rise in demand for needleless connectors.

Anti-Infective dominated the market with a revenue share of over 25.0% in 2014. Home administration of anti-infective therapy is preferred by patients who have chronic infections that cannot be treated through oral agents. It is considered as the most user friendly home infusion therapy.

North America accounted for more than 40% of the home infusion therapy market in 2014 on account of the presence of large geriatric population base. Presence of sophisticated healthcare infrastructure and favorable reimbursement plans laid out by regulatory bodies are also expected to make significant contributions towards market growth.

Asia Pacific is expected to emerge as a high growth market over the forecast period. Presence of large unmet needs in the emerging economies such as China and India. Rising patient awareness levels regarding the benefits of home infusion therapies over the in-hospital infusion therapies is expected to further boost the growth of this region.

Key players of home infusion therapy market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, CareFusion Corporation and Hospira Inc. Mergers and acquisitions and entering into strategic collaborations with healthcare providers are two key sustainability strategies adopted by these market participants.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumption
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Home Infusion Therapy - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. Home Infusion Therapy Industry Outlook

  • 3.1. Home infusion therapy market segmentation
  • 3.2. Home infusion therapy market size and growth prospects
  • 3.3. Home infusion therapy market dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Home infusion therapy market PESTEL analysis, 2014
  • 3.7. Home infusion therapy - Unmet need analysis

Chapter 4. Home Infusion Therapy Product Outlook

  • 4.1. Home infusion therapy market share by product, 2014 & 2022
  • 4.2. Infusion pumps
    • 4.2.1. Infusion pumps market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.3. Intravenous sets
    • 4.3.1. Intravenous sets market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.4. Needleless connectors
    • 4.4.1. Needleless connectors market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 5. Home Infusion Therapy Application Outlook

  • 5.1. Home infusion therapy market share by application, 2014 & 2022
  • 5.2. Anti-infective
    • 5.2.1. Anti-infective market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.3. Hydration therapy
    • 5.3.1. Hydration therapy market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Chemotherapy market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.5. Enteral Nutrition
    • 5.5.1. Enteral nutrition market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.6. Parenteral nutrition
    • 5.6.1. Parenteral nutrition market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.7. Specialty pharmaceuticals
    • 5.7.1. Specialty pharmaceuticals market estimates and forecasts, 2012 - 2022 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 6. Home infusion therapy Regional Outlook

  • 6.1. Home infusion therapy market share by region, 2014 & 2022
  • 6.2. North America
    • 6.2.1. North America home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
      • 6.2.1.1. U.S. market estimates and forecasts
      • 6.2.1.2. Canada market estimates and forecasts
    • 6.2.2. North America home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
      • 6.2.2.1. U.S. market estimates and forecasts
      • 6.2.2.2. Canada market estimates and forecasts
  • 6.3. Europe
    • 6.3.1. Europe home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
      • 6.3.1.1. Germany market estimates and forecasts
      • 6.3.1.2. UK market estimates and forecasts
    • 6.3.2. Europe home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
      • 6.3.2.1. Germany market estimates and forecasts
      • 6.3.2.2. UK market estimates and forecasts
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
      • 6.4.1.1. China market estimates and forecasts
      • 6.4.1.2. Japan market estimates and forecasts
    • 6.4.2. Asia Pacific home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
      • 6.4.2.1. China market estimates and forecasts
      • 6.4.2.2. Japan market estimates and forecasts
  • 6.5. Latin America
    • 6.5.1. Latin America home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
    • 6.5.2. Latin America home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA home infusion therapy market estimates and forecasts, by product, 2012 - 2022 (USD Million)
    • 6.6.2. MEA home infusion therapy market estimates and forecasts, by application, 2012 - 2022 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Terumo Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. B. Braun Melsungen
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Caesarea Medical Electronics
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. Smiths Medical
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. CareFusion Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Financial Performance
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Initiatives
  • 7.6. ICU Medical Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. JMS Co. Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. Baxter Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
  • 7.9. Fresenius Kabi
    • 7.9.1. Company Overview
    • 7.9.2. Financial Performance
    • 7.9.3. Product Benchmarking
    • 7.9.4. Strategic Initiatives

List of Tables

  • 1. Home Infusion Therapy- Industry Summary and Key Buying Criteria
  • 2. Home Infusion Therapy Market by Product, (USD million), 2012 - 2022
  • 3. Home Infusion Therapy Market by Application, (USD million), 2012 - 2022
  • 4. Home Infusion Therapy Market by Region, (USD million), 2012 - 2022
  • 5. Home Infusion Therapy Market - Key market drivers analysis
  • 6. Home Infusion Therapy Market - Key market restraints analysis
  • 7. Infusion Pumps Market, 2012 to 2022 (USD million)
  • 8. Intravenous Sets Market, 2012 to 2022 (USD million)
  • 9. IV Cannulas Market, 2012 to 2022 (USD million)
  • 10. Needle Less Connectors Market, 2012 to 2022 (USD million)
  • 11. Anti-Infective Market, 2012 to 2022 (USD million)
  • 12. Hydration Therapy Market, 2012 to 2022 (USD million)
  • 13. Chemotherapy Market, 2012 to 2022 (USD million)
  • 14. Enteral Nutrition Market, 2012 to 2022 (USD million)
  • 15. Parenteral Nutrition Market, 2012 to 2022 (USD million)
  • 16. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
  • 17. Others Market, 2012 to 2022 (USD million)
  • 18. Global Home Infusion Therapy Market, By Region, 2012 to 2022 (USD million)
  • 19. North America Home Infusion Therapy Demand, By Product, (USD million), 2012 - 2022
  • 20. North America Home Infusion Therapy Demand, By Application, (USD million), 2012 - 2022
  • 21. Europe Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 22. Europe Home Infusion Therapy Demand, By Applications, (USD million), 2012 - 2022
  • 23. Asia Pacific Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 24. Asia Pacific Home Infusion Therapy Demand, By Applications, (USD million), 2012 - 2022
  • 25. Latin America Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 26. Latin America Home Infusion Therapy Demand, By Application, (USD million), 2012 - 2022
  • 27. MEA Home Infusion Therapy Demand, By Products, (USD million), 2012 - 2022
  • 28. MEA Home Infusion Therapy Demand, By Application, (USD million), 2012 - 2022

List of Figures

  • 1. Home Infusion Therapy Market Segmentation
  • 2. Global Home Infusion Therapy Market Revenue, 2012 - 2022
  • 3. Home Infusion Therapy Market Dynamics
  • 4. Key Opportunities Prioritized
  • 5. Industry Analysis - Porter's
  • 6. Home Infusion Therapy PESTEL Analysis, 2012
  • 7. Global Home Infusion Therapy Market , By Product, (USD million), 2012 - 2022
  • 8. Infusion Pumps Market, 2012 to 2022 (USD million)
  • 9. Intravenous Sets Market, 2012 to 2022 (USD million)
  • 10. IV Cannulas Market, 2012 to 2022 (USD million)
  • 11. Needleless Connectors Market, 2012 to 2022 (USD million)
  • 12. Global Home Infusion Therapy Market , By Application, (USD million), 2012 - 2022
  • 13. Anti-Infective Market, 2012 to 2022 (USD million)
  • 14. Hydration Therapy Market, 2012 to 2022 (USD million)
  • 15. Chemotherapy Market, 2012 to 2022 (USD million)
  • 16. Enteral Nutrition Market, 2012 to 2022 (USD million)
  • 17. Parenteral Nutrition Market, 2012 to 2022 (USD million)
  • 18. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
  • 19. Others Market, 2012 to 2022 (USD million)
  • 20. Global Home Infusion Therapy Market, By Region 2012 to 2022 (USD million)
  • 21. Infusion Pumps Market, 2012 to 2022 (USD million)
  • 22. Intravenous Sets Market, 2012 to 2022 (USD million)
  • 23. IV Cannulas Market, 2012 to 2022 (USD million)
  • 24. Needleless Connectors Market, 2012 to 2022 (USD million)
  • 25. Anti-Infective Market, 2012 to 2022 (USD million)
  • 26. Hydration Therapy Market, 2012 to 2022 (USD million)
  • 27. Chemotherapy Market, 2012 to 2022 (USD million)
  • 28. Enteral Nutrition Market, 2012 to 2022 (USD million)
  • 29. Parenteral Nutrition Market, 2012 to 2022 (USD million)
  • 30. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
  • 31. Others Market, 2012 to 2022 (USD million)
  • 32. Home Infusion Therapy market - Company market share analysis, 2014 (%)
Back to Top